Eleuthero: benefits, dosage, contraindications

Updated on

Eleuthero (Eleutherococcus senticosus), also known as Siberian ginseng, is a plant mainly cultivated in China, Korea, Japan, and Siberia. It is a thorny shrub 2 to 3 meters tall. It has long stems with palmate leaves and develops small flowers grouped into globular umbels. The male flowers are purple while the female flowers are yellow. The fruits of eleuthero are black berries. Its roots are used therapeutically and - more rarely - the berries. Eleuthero has been used for over 2000 years in traditional Chinese medicine, where it is called ci wu jia. It was used to prevent colds and flu and to increase vitality and energy. More recently, it has been used by Russian cosmonauts to improve alertness and energy levels and to help adapt to the stresses of life in space. Its roots contain eleutherosides responsible for its adaptogenic character, meaning that it helps the body adapt to stress and restore the normal balance of its functions. Other bioactive components include isofraxidine, syringin (a phenylpropanoid glucoside), and nutrients. The nutrients include magnesium, manganese, vitamins A, and E. Eleuthero is reputed to stimulate the immune defenses, improve resistance to stress, and boost physical performance during difficult periods. The EMA recommends it as a traditional herbal medicine for symptoms of asthenia such as fatigue and weakness.

Other name(s) 

Siberian Ginseng, Ciwujia

Scientific name(s)

Eleutherococcus Senticosus, Acanthopanax senticosus, Acanthopanacis senticosi

Family or group: 

Plants

Active ingredients:

Coumarins

Saponins

Lignans

Eleutherosides


Indications

Rating methodology

EFSA approval.

Several clinical trials (> 2) randomized controlled with double blind, including a significant number of patients (>100) with consistently positive outcomes for the indication.
Several clinical trials (> 2) randomized controlled with double blind, and including a significant number of patients (>100) with positive outcomes for the indication.
One or more randomized studies or multiple cohorts or epidemiological studies with positive outcomes for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or contradictory.
Lack of clinical studies to date that can demonstrate the indication.


Herpes
✪✪✪✪✪

A clinical study in men suffering from recurrent genital herpes infections shows that taking a specific eleutherococcus extract (Elagen), standardized to contain 0.3% eleutherosides, reduces the frequency, severity, and duration of outbreaks. More recently, the Elagen formulation contains at least 2g of dried root equivalent in each capsule of concentrated Eleutherococcus Senticosus extract standardized around 0.4% eleutheroside B and 0.5% eleutheroside E.

Posologie

posologieOral: root

posologie2000 mg

formulationstandardized extract


Fatigue
✪✪✪✪✪

Eleutherococcus is indicated for decreased mental and physical capacity such as weakness, exhaustion, fatigue, and loss of concentration, as well as during convalescence, according to ESCOP (European Scientific Cooperative on Phytotherapy) and EMA (European Medicines Agency). Several clinical studies confirm these indications. A randomized, double-blind, placebo-controlled trial of 300 mg / day (dry extract) for 8 weeks assessed health-related quality of life scores in 20 elderly people. Improvements were observed in social functioning after 4 weeks of treatment but did not persist up to 8 weeks. It seems that improvements decrease with continued use, which may help explain the practice of administering eleutherococcus for 6 weeks with a break of 2 weeks before starting again. In another randomized, placebo-controlled clinical study in 76 people with chronic fatigue, no statistically significant reduction in fatigue was demonstrated, however, interesting results were noted in some subgroups. For example, in subjects with moderate fatigue, significant improvement was observed after 2 months in those taking eleutherococcus compared to those on placebo. The product used provided 2.24 mg of eleutherosides from 2 g of extract consumed in total per day. Siberian ginseng's ability to increase levels of norepinephrine, serotonin, adrenaline, and cortisol provides a theoretical basis for its use in situations of fatigue. However, controlled studies remain limited.

Posologie

posologieOral: root

posologie300 - 2000 mg

duration6 - weeks

formulationalcoholic extract, dry extract


Cold
✪✪✪✪✪

Some clinical research shows that taking a combination containing eleutherococcus and andrographis (Kan Jang) orally improves cold symptoms when started within 72 hours of symptom onset. Some symptoms may improve after 2 days of treatment; however, it generally requires 4 to 5 days of treatment to achieve maximum symptom relief. The combination of eleutherococcus and andrographis relieves cold symptoms better than echinacea or placebo in children, according to studies.

Posologie

posologieOral: root

posologie400 - 1200 mg

duration5 - days

formulationstandardized extract, dry extract


Synergies


Type 2 Diabetes
✪✪✪✪✪

A clinical study conducted in adults with type 2 diabetes shows that taking a specific eleutherococcus extract, standardized to contain eleutherosides E and B at 1.12%, at a dose of 480 mg per day for 3 months, lowers fasting and postprandial blood glucose levels, reduces glycated hemoglobin (HbA1c), and decreases triglycerides and total cholesterol levels compared to placebo.

Posologie

posologieOral: root

posologie480 mg

duration3 - months

formulationstandardized extract


Stress
✪✪✪✪✪

In a randomized controlled study on 144 participants suffering from asthenia and reduced work capacity related to chronic stress, Eleutherococcus improved parameters over time, and a significant difference was found in mental fatigue and agitation, favoring Eleutherococcus supplementation compared to a 2-day professional stress management training. A placebo-controlled study conducted over 6 weeks examined the effects of an ethanolic extract of Eleutherococcus (8 ml/day, equivalent to 4 g/day of dried root) in athletes. In the study, the treatment led to an increase in cortisol levels, which may be consistent with animal research, suggesting a stress threshold below which Eleutherococcus increases the stress response and above which it decreases the stress response. Finally, a small clinical study conducted in healthy women aged 20 to 68 who were stressed over an extended period shows that a single dose of 270 mg of a formulation (ADAPT-232) containing Eleutherococcus, Rhodiola, and Schisandra improves attention as well as cognitive speed and accuracy compared to a placebo.

Posologie

posologieOral route: root

posologie120 mg

duration6 - weeks

formulationalcoholic extract, ADAPT 232, dry extract


Synergies


Improve adaptation capability
✪✪✪✪✪

Eleutherococcus is classified as an adaptogen known for its ability to enhance stress response. Studies have shown that Eleutherococcus primarily acts on the hypothalamic-pituitary-adrenal (HPA) axis, modulating the production of neurotransmitters and hormones like cortisol and catecholamines. This helps prevent exhaustion related to chronic stress and maintain an effective adaptive response. Eleutherococcus seems to adjust the stress response according to the individual's level, increasing resistance in moderately stressful situations while attenuating excessive stress reactions. It has also been demonstrated to possess anxiolytic and antioxidant properties, making it an effective supplement for enhancing mental and physical endurance.

Posologie

posologieOral route: root

posologie240 mg

duration4 - weeks

formulationstandardized extract, dry extract


Properties


Adaptogen

full-leaffull-leaffull-leaffull-leaf

Siberian ginseng seems to modify the levels of various neurotransmitters and hormones involved in the stress response, mainly at the HPA axis (hypothalamic-pituitary-adrenal axis). Various mechanisms have been proposed, including the inhibition of catechol-O-methyltransferase, which inactivates catecholamines. Consequently, catecholamine levels do not deplete, and the release of new catecholamines by nerve synapses decreases. Theoretically, this effect reduces the risk of exhausting the body's adaptive responses to stress. Moreover, it has been shown that eleutherosides enhance carbohydrate metabolism and energy supply and increase the synthesis of proteins and nucleic acids, although the direct molecular targets responsible for this adaptive response remain unknown. It has also been reported in vitro that eleutherosides bind to sites of progestogenic, estrogenic, mineralocorticoid, and glucocorticoid receptors and could therefore theoretically exert numerous important pharmacological actions in the body's response to stress. Thus, the herb's overall action has been described as "adaptogenic." Although the responsible mechanism of action remains unclear, several theories have been proposed to explain the effect of Siberian ginseng on allostatic systems. Indeed, research has shown that Siberian ginseng can act in various ways according to the stage of the stress response to support the "stress system." Research suggests there is a threshold of stress below which the herb increases the stress response and above which it decreases the stress response.

Usages associés

Stress, Fatigue, Improve adaptability

Neurological

full-leaffull-leaffull-leafempty-leaf

Eleuthero protects neurons and inhibits apoptosis of brain cells. In animal research, an aqueous extract of eleuthero inhibited inflammation and microglial activation in cerebral ischemia. In cultured rat cortical neurons, eleuthero extracts have been shown to have protective effects on neurite regeneration and synapse reconstruction in cultured rat cortical neurons damaged by beta-amyloid. This effect is thought to be due, at least in part, to eleutheroside B. In mice, eleutheroside E prevented sleep deprivation-induced behavioral disorders, including reduced latency to enter a dark chamber and locomotion, as well as increased monoamines (serotonin and dopamine) in the hippocampus, suggesting that this component of eleuthero could be valuable for stress experienced due to chronic insomnia.

Usages associés

Stress

Cardiovascular

full-leaffull-leafempty-leafempty-leaf

Eleuthero, when administered orally to rats (at 1 ml/kg for 8 days), showed protective effects on the heart. These benefits, which include protection against cardiac rhythm disorders (antiarrhythmics), appear to be due to an increase in levels of natural opioid peptides in the body. In the laboratory, eleuthero also shows a blood vessel relaxation effect. This effect could be caused by several mechanisms, such as increased nitric oxide production (a gas that relaxes blood vessels), activation of muscarinic receptors (receptors involved in nervous system control), or by influencing certain channels in cells that regulate the passage of potassium ions. In a study conducted on cultured neonatal rat heart cells, a specific component of eleuthero, acanthopanax senticoside B (part of the plant's saponins), protected these cells against damage caused by oxidative stress. It accomplished this by reducing lipid peroxidation (a type of cellular damage) and increasing the activity of the body's antioxidant defense mechanisms.


Hypoglycemic

full-leaffull-leafempty-leafempty-leaf

Eleuthero possesses hypoglycemic properties observed in studies conducted in the laboratory (in vitro) and on animals (in vivo). - It reduces glucose absorption by inhibiting an enzyme called alpha-glucosidase, thus limiting the amount of glucose entering the bloodstream. - Eleutherosides, components of eleuthero, particularly eleutherosides E and B, allow glucose to enter cells without depending on insulin, the hormone usually required for this process. - Eleuthero may counter obstacles to glucose transfer caused by certain proteins (β-lipoproteins) in cell membranes. - Syringin, a component, improves glucose utilization and can lower blood glucose levels. This may be due to increased acetylcholine release, which stimulates insulin release, or to the promotion of β-endorphin secretion, leading to a decrease in blood glucose.

Usages associés

Type 2 Diabetes

Immunomodulator

full-leaffull-leafempty-leafempty-leaf

Eleutherococcus extract has shown immunomodulatory effects, including increased cellular and humoral activity, activation and proliferation of immunocompetent cells, and stimulation and inhibition of cytokine synthesis, in human, animal, and in vitro research. According to a review, immunomodulatory polysaccharides or saponins isolated from eleutherococcus stimulated macrophages, promoted antibody formation, activated the complement, and increased T lymphocyte proliferation. In rabbits, eleutherococcus extract had a sustained immunostimulant effect and increased phagocytic activity. In vitro, syringin, a constituent of eleutherococcus root, stimulated the phagocytosis of rat blood macrophages (immune system cells that help fight infections). Also, eleutherococcus reduced the occurrence of allergic reactions. Histamine release from rat peritoneal mast cells, as well as TNF-alpha and IL-6 secretion, was also inhibited. Similar results have been observed in other animal studies, suggesting an anti-allergic effect of eleutherococcus.

Usages associés

Herpes, Respiratory infections

Antiviral

full-leafempty-leafempty-leafempty-leaf

In vitro, a liquid extract of eleutherococcus inhibited the productive replication of RNA viruses, human rhinovirus, respiratory syncytial virus, and influenza A virus. However, it does not seem to affect DNA viruses such as adenovirus or herpes simplex type 1 virus.

Usages associés

Cold, Herpes, Respiratory infections


Safety dosage

Adult from 17 year(s): 200 mg - 1000 mg (dry extract)

- Root decoction: 0.5 to 4 g of dried roots in 150 ml of boiling water, 1 to 2 cups per day. - Mother tincture: up to 4 ml per day in 2 or 3 doses - Capsules or tablets: up to 1 g of root powder per day in 2 or 3 doses, which corresponds to 200 mg of dry extract per capsule. Extracts are generally standardized to provide 0.1% Eleutheroside E (syringareresinol diglucoside) and 0.5% Eleutheroside B (syringin). It is advised not to exceed 6 weeks.


Interactions

Médicaments

Antiplatelet/Anticoagulant: moderate interaction

Eleutherococcus has anticoagulant effects; theoretically, supplementation of Eleutherococcus alongside anticoagulant therapy increases bleeding risks.

Antidiabetic: moderate interaction

In healthy individuals, Eleutherococcus supplementation increases postprandial blood glucose but has a hypoglycemic action in diabetic patients. In combination with antidiabetic drugs, Eleutherococcus supplementation might interfere with the treatment.

Central nervous system depressants: low interaction

Some studies present the sedative properties of Eleutherococcus; therefore, its concurrent use with sedatives could have additive effects and side effects.

Cytochrome P450 substrate: low interaction

Eleutherococcus supplementation appears to interact with cytochrome P450 substrate medication. Inhibiting cytochromes P450 1A2, 2C9, 2D6, and 3A4, Eleutherococcus intake interferes with the metabolism of substances degraded by cytochrome P450 enzymes. Examples: Clozapine, Theophylline, Diclofenac, Tamoxifen, Metoprolol, Statins, Cyclosporine, and others.

Immunosuppressant: low interaction

Due to its immuno-stimulating properties, Eleutherococcus interferes with immunosuppressive treatments.

Plantes ou autres actifs

Antiplatelet/Anticoagulant: moderate interaction

Eleutherococcus has anticoagulant effects; theoretically, supplementation of Eleutherococcus alongside anticoagulant treatment increases bleeding risks.

Sedative: low interaction

Some studies present the sedative properties of Eleutherococcus, thus its concurrent use with sedatives could have additive effects and side effects. Example: Ashwagandha, Lemon balm, Hawthorn, Chamomile, and others.


Precautions

Child from 12 to 17 year(s): use with caution

Supplementation with Eleutherococcus is possible in adolescents aged 12 to 16 years, but dosages are not available.

Pregnant woman: avoid

Use is not recommended due to a lack of reliable and sufficient information.

Breastfeeding woman: avoid

Use is not recommended due to a lack of reliable and sufficient information.

Child up to 12 year(s): avoid

Use in children under 12 years has not been established due to the lack of adequate data.


Contraindications

High blood pressure: prohibited

Eleutherococcus is contraindicated in individuals whose blood pressure exceeds 180/90. Eleutherococcus may potentially exacerbate hypertension.

Cardiovascular diseases: prohibited

Eleutherococcus may cause palpitations, tachycardia, and hypertension and should be used with caution in patients with cardiovascular disorders (e.g., atherosclerotic or rheumatic heart disease). It may also cause headaches and pericardial pain in patients with rheumatic heart disease.